BioSpace News Archive

Plus Therapeutics, Inc. announced that Marc Hedrick, M.D., President and Chief Executive Officer, will present in-person at the H.C. Wainwright 24th Annual Global Investment Conference on Wednesday, September 14, 2022, at 2:00 p.m. ET, and host investor meetings.

H-CYTE, Inc., a medical biosciences company, announced that the Company completed the acquisition of Jantibody.

Axsome Therapeutics, Inc. announced that it has enrolled the first patient in the ADVANCE-2 trial of AXS-05, an investigational treatment for Alzheimer’s disease agitation.

Bio-Techne Corporation announced that Exosome Diagnostics, a Bio-Techne brand, will present initial data on their novel non-invasive saliva profiling assay for Sjögren’s Syndrome diagnosis and monitoring at the 15th International Symposium on Sjögren’s Syndrome in Rome, Italy on Friday Sept 9.

Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress” or “the Company”) today announced that Lindsay A. Rosenwald, M.D., Chairman and Chief Executive Officer, will present a corporate update virtually at the H.C. Wainwright 24th Annual Global Investment Conference and the Company will participate in one-on-one meetings on Tuesday, September 13, 2022.

PolarityTE, Inc. announced that Jeff Dyer, PhD, has decided to resign from its Board of Directors, effective immediately.

ValGenesis Inc. announces the final speaker lineup of ValConnect 2022, its annual user conference that runs from Monday, September 26th through Wednesday September 28th.

Cryoport, Inc. (Nasdaq: CYRX) (“Cryoport” or the “Company”), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced it has entered into a strategic relationship with BioLife Plasma Services, part of the global biopharmaceutical company Takeda.

Alumis Inc., a precision immunology company that is reimagining the discovery, development and treatment of autoimmune disorders, announced that Jörn Drappa, M.D., Ph.D., has been appointed as chief medical officer.

NANO-X IMAGING LTD, an innovative medical imaging technology company, announces that Company management will participate in two investor conferences in the month of September 2022.